Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts. Show more

PO Box 30, Winchester, MA, 01890, United States

Biotechnology

Healthcare

Market Cap

7.136M

52 Wk Range

$0.54 - $1.96

Previous Close

$0.61

Open

$0.60

Volume

179

Day Range

$0.60 - $0.60

Enterprise Value

-11.72M

Cash

15.59M

Avg Qtr Burn

-1.436M

Insider Ownership

21.40%

Institutional Own.

65.57%

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
SYNB1353 Details Homocystinuria	Phase 2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
SYNB8802 Details Primary hyperoxaluria	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
SYNB1891 Details Solid tumor/s, Cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Labafenogene marselecobac (previously SYNB1934) Details Phenylketonuria	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.